Liver damage implicated in high blood pressure

Fatty liver disease or non-alcoholic steatohepatitis (NASH) is a liver disease caused by obesity where the liver tissue is infiltrated with fat, disrupting normal liver enzymes. This alternation in liver enzymes, particularly GGT, has been found to be associated with the development of high blood pressure. NASH has no symptoms, but can be detected via blood tests and ultrasound and can progress to irreversible liver damage, called cirrhosis. Researchers are calling for the condition to be included into the ‘metabolic syndrome’ classification, along with sleep apnea, reflux, insulin insensitivity, hypertension, obesity, high cholesterol, and dyslipidemia, which are risk factors for heart disease and stroke.

Source: summary of medical news story as reported by Science Daily

Related Disease Topics:

• Fatty liver disease
• Non-alcoholic steatohepatitis
• NASH
• Liver disease
• Obesity
• High blood pressure
• Cirrhosis
• Metabolic syndrome
• Sleep apnea
• Reflux
• Insulin insensitivity
• Hypertension
• Obesity
• High cholesterol
• Dyslipidemia
• Heart disease
• Stroke

Article Source Details

About: Liver damage implicated in high blood pressure

Date: 3 November 2005

Source: Science Daily

URL: http://www.sciencedaily.com/releases/2005/11/051103080111.htm

Related Medical Topics

This summary article refers to the following medical categories:

• Cause of fatty liver disease
• Cause of non-alcoholic steatohepatitis
• Cause of NASH
• Cause of liver disease
• Cause of cirrhosis
• Cause of elevated liver enzymes
• Cause of change in liver enzymes
• Cause of elevated GGT
• Cause of GGT
• Risk and elevated liver enzymes
• Risk and change in liver enzymes
• Risk and elevated GGT
• Risk and GGT
• Risk and fatty liver disease
• Risk and non-alcoholic steatohepatitis
• Risk and NASH
• Risk and liver disease
• Risk and obesity
• Risk and high blood pressure
• Risk and cirrhosis
• Risk and metabolic syndrome
• Risk and sleep apnea
• Risk and reflux
• Risk and insulin insensitivity
• Risk and hypertension
• Risk and obesity
• Risk and high cholesterol
• Risk and dyslipidemia
• Risk and heart disease
• Risk and stroke
• Research
• Research and fatty liver disease
• Research and non-alcoholic steatohepatitis
• Research and NASH
• Research and liver disease
• Research and obesity
• Research and high blood pressure
• Research and cirrhosis
• Research and elevated liver enzymes
• Research and change in liver enzymes
• Research and elevated GGT
• Research and GGT
• Research and obesity
• Research and overweight

More News Topics

Search Specialists by State and City